الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 113 |  |  |
| | | from | 113 | | |
Abstract
Incidence of HCC decreased significantly after Direct Acting Antivirals therapy in chronic HCV patients. Decreased incidence was not affected by hepatic fibrosis stage in those patients. On the other side, Incidence of HCC was associated with poorer hepatic synthetic function in HCV patients who received Direct-Acting Antivirals.